Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2026 16:30 ET | Source: Recursion Pharmaceuticals

Recursion Announces Board Transition

Salt Lake City, UT, April 30, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Chris...
April 29, 2026 07:59 ET | Source: Recursion Pharmaceuticals

Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6

Salt Lake City, UT, April 29, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide...
April 07, 2026 08:00 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation...
March 25, 2026 07:59 ET | Source: Recursion Pharmaceuticals

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki...
February 25, 2026 06:30 ET | Source: Recursion Pharmaceuticals

Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple...
February 23, 2026 08:00 ET | Source: Recursion Pharmaceuticals

Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC

Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured...
February 23, 2026 07:55 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in...
February 18, 2026 08:30 ET | Source: Recursion Pharmaceuticals

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25

Salt Lake City, UT, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide...
February 12, 2026 07:59 ET | Source: Recursion Pharmaceuticals

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6,...
January 06, 2026 07:59 ET | Source: Recursion Pharmaceuticals

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO &...